Glenbrook’s $1.90 Buy‑In Signals Strong Confidence in Senestech’s Growth Path
Glenbrook Capital’s bulk buy of Senestech shares at $1.87‑$1.98 shows deep faith in its fertility‑control platform and could spark a market rally after New Zealand approval.
3 minutes to read